CORZW — Core Scientific, Inc.

Core Scientific Q1 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Total Revenue: $79.5 million, down 16% sequentially.
• Adjusted EBITDA: Negative $6.1 million.
• Bitcoin Production: 719 Bitcoin mined in Q1, down from 974 in Q4 2024.
• CapEx: Approximately $90 million, with over half funded by CoreWeave.
• Liquidity: $780 million, including cash, cash equivalents, and Bitcoin.
• Share Count: Pro forma fully diluted share count of approximately 502 million shares.

2. Strategic Updates and Business Highlights

• AI Infrastructure Demand: Core Scientific is positioned to capitalize on the growing demand for high-density infrastructure driven by AI workloads. The company aims to diversify its customer base beyond CoreWeave, which currently represents a significant portion of its business.
• CoreWeave Contracts: The contracts with CoreWeave are foundational, structured as take-or-pay agreements that minimize capital outlay and leverage. CoreWeave is funding most capital expenditures, allowing Core Scientific to maintain a lighter balance sheet.
• Capacity Expansion: The company is advancing the build-out of 570 megawatts for CoreWeave across multiple sites, with significant progress at the Denton facility, expected to deliver 250 megawatts by the end of 2025 and 590 megawatts by early 2027.
• Customer Pipeline: The sales pipeline is expanding, particularly with large enterprises beginning to adopt AI use cases, indicating potential for substantial deployments.

3. Forward Guidance and Outlook

• Customer Base Diversification: The goal is to have CoreWeave represent less than 50% of billable capacity by the end of 2028.
• Construction Milestones: The company expects to deliver the first tranche of 8 megawatts of billable capacity this month, with an additional 40 megawatts by the end of Q2 2025.
• Long-Term Growth: Core Scientific aims to add approximately 300 megawatts of billable capacity by the end of 2027 and is exploring new geographic expansions.

4. Bad News, Challenges, or Points of Concern

• Revenue Decline: The 16% sequential decline in revenue is attributed to mining disconnections and relocations as the company transitions to high-density colocation.
• Negative EBITDA: The company reported a negative adjusted EBITDA, indicating ongoing financial challenges during the transition.
• Market Dynamics: There are concerns regarding potential softening demand for AI infrastructure, although management remains optimistic about sustained demand.
• Tariff Impacts: Increased CapEx requirements due to tariffs could lead to higher lease rates, affecting overall profitability.

5. Notable Q&A Insights

• Customer Contracts: Management indicated that large enterprises are moving faster towards finalizing contracts compared to hyperscalers, which may take longer due to their larger scale and complexity.
• CoreWeave's Role: There is confidence that the relationship with CoreWeave will not deter other hyperscale customers, as successful execution of projects will enhance credibility.
• Future Capacity: Discussions with utilities regarding future power contracts are ongoing, and management is confident in achieving the planned capacity growth.
• M&A Strategy: The company is focused on acquiring assets that align with its high-density infrastructure strategy, while also considering opportunities that diversify its workload.

This summary encapsulates the key points from the earnings call, highlighting both the positive strategic initiatives and the challenges faced by Core Scientific as it transitions its business model.